ADMT 最新10-Q变化
将 ADMT 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-08-19 与上一份 10-Q · 2026-02-13
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +12 | −19 | ~4 | 4 |
| 市场风险(第3项) | 文字有新增/删除 | 0 | 0 | ~3 | 1 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~3 | 3 |
| 风险因素 | 公司称无重大变化(指向 10-K) | — | — | — | — |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):法律诉讼、其他信息
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-08-19
The Company is a corporation that was organized under the laws of the State of Delaware on November 24, 1969. Our operations are conducted through ADM. Sonotron Medical Systems, Inc. (“SMI”), a former wholly owned subsidiary of ADM, had been inactive for several years and was dissolved during the fi…
Revenues for the three months ended June 30, 2026 decreased by $107,420, or 11.0%, compared to the same period in 2025. Chemical segment revenue decreased by $9,200 to $325,860, Electronics segment revenue decreased by $41,692 to $472,990, and Engineering segment revenue decreased by $56,528 to $67,…
Gross profit for the three months ended June 30, 2026 decreased by $86,243, or 17.4%, compared to the same period in 2025, and gross profit margin declined to 46% from 49%. Gross margin declined across all three segments, with the largest declines in the Chemical segment, to 30% from 39%, and the En…
Operating expenses for the three months ended June 30, 2026 increased by $43,646, or 12.1%, compared to the same period in 2025, driven by increases of $30,447 in the Chemical segment and $30,616 in the Electronics segment, partially offset by a $15,904 decrease in the Engineering segment.
Operating income (loss) for the three months ended June 30, 2026 decreased by $129,889 compared to the prior year, resulting in an operating loss of $19,772 for the current period as compared to operating income of $109,234 in the prior year period.
相对上期删除的文字 · 来源:10-Q · 2026-02-13
The Company is a corporation that was organized under the laws of the State of Delaware on November 24, 1969. Our operations are conducted through ADM and its subsidiary Sonotron.
Revenues for the three months ended December 31, 2025, increased by $53,578 compared to the same period in 2024. The increase was driven by a $14,980 rise in the Chemical segment and a $96,460 increase in the Electronics segment, partially offset by a $57,862 decline in the Engineering segment.
Revenues for the nine months ended December 31, 2025, increased by $216,870 compared to the same period in 2024. The increase was driven by a $44,554 rise in the Chemical segment and a $333,630 increase in the Electronics segment, partially offset by a $163,314 decline in the Engineering segment.
Gross profit for the three months ended December 31, 2025 increased by $4,317. This increase was primarily due to a $4,017 increase in the Chemical segment and an increase of $64,721 in the Electronics segment offset by a $64,421 decrease in the Engineering segment.
Gross profit for the nine months ended December 31, 2025 decreased by $78,278. This decrease was primarily due to a $129,041 increase in the Electronics segment offset by a decrease of $59,190 in the Chemicals segment and a $148,129 decrease in the Engineering segment.
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议